Some patients taking popular GLP-1 weight loss drugs may be able to keep the weight off while taking injections less often, ...
A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...
Researchers at Eli Lilly and others published a phase II trial this week that combined semaglutide, the active ingredient in ...
With the rise in the use of weight loss medications, new questions are emerging about where the body positivity movement fits ...
Popular weight-loss drugs such as Ozempic, Wegovy, and Mounjaro may do more than help people shed pounds. New research suggests these GLP-1 medications could also help protect the heart after a heart ...
New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.
A scoop of pre-workout can feel like a shortcut to motivation, especially for teens and young adults juggling school, work, and training. But new findings from the Canadian Study of Adolescent ...
In a recent review, a small group of patients received the injections less frequently but still maintained weight loss and health benefits.
GLP‑1 weight‑loss drugs like Ozempic may help the heart heal after a heart attack, offering potential new treatment options, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results